手術機器人市場規模：按組件、按應用、按地區、範圍和預測

手術機器人市場規模及預測

2024年手術機器人市場規模為100.3億美元，預計2024年至2031年複合年增長率為17.97%，到2031年將達到335.5億美元。手術機器人是一種微創手術，利用電腦控制的機器人系統在手術過程中協助外科醫生。機器人手術是使用自動化技術進行的手術。機器人輔助手術旨在解決現有微創手術的缺點，提升醫師進行傳統開放式手術的能力。在機器人輔助的微創手術中，醫生使用兩種方法之一來控制它們，而不是物理操作工具。這些方法包括直接遙控方法和電腦控制方法。遠端操縱器是一種遠端操縱器，可讓外科醫生在手術過程中執行所需的精確運動。然後，機械手臂使用末端執行器和儀器來模仿這些運動並執行外科手術。在電腦控制系統中，外科醫生使用電腦指令來驅動機械手臂或末端執行器，但這些系統可能仍有遠端操縱器用於輸入。

電腦控制的優點之一是醫生不需要親自在場，可能允許遠端手術。儲存設備對於確保無縫機器人輔助手術至關重要。

根據患者的醫療記錄，這些儲存解決方案具有多種用途，包括儲存用於校準調整的特定資訊、檢測儲存決策系統中的差異以及監控資料壽命。

作為參考資料

世界手術機器人市場動態

塑造全球手術機器人市場的關鍵市場動態

主要市場驅動因子

微創方法：

機器人輔助手術 (RAS) 提供了傳統開放性手術的微創替代方案。這種方法為患者帶來了多種好處，包括切口更小、失血更少、恢復時間更快、術後疼痛更少。較小的切口還可以降低感染風險並最大程度地減少疤痕，從而改善患者的整體體驗和結果。

提高精度和控制：

RAS 增強了手術器械的精確度和控制。機械手臂可以比人手更精確地進行運動，從而最大限度地減少手部顫抖並提高手術精度。這種增強的控制對於複雜而精細的手術特別有益，因為即使是最輕微的錯誤也可能造成嚴重的後果。外科醫生可以以更高的精度進行複雜的手術，從而獲得更好的臨床結果。

改進的視覺化：

RAS系統配備了高清3D攝像頭，可以放大手術部位。這種先進的可視化使外科醫生能夠詳細瞭解解剖結構，從而有助於在手術過程中做出明智的決策。提高組織和器官的可視性可以更輕鬆地識別和保存關鍵結構，從而減少併發症的機會。

對微創手術的需求不斷增加：

隨著越來越多的患者更喜歡微創手術而不是傳統的開放性手術，對微創手術的需求正在增加。這一趨勢是由微創手術的優點所推動的，包括更快的恢復時間、減輕疼痛以及更快地恢復日常活動。因此，對能夠更準確、更有效地執行這些微創手術的手術機器人的需求不斷增長。

人口老化：

世界人口老化正在增加對複雜外科手術的需求。老年患者通常有合併症，傳統的開放性手術有風險。 RAS 減少了與手術相關的身體創傷，使其成為這些患者的更安全的選擇。機器人手術的精確性和微創性使其特別適合老年患者，他們的康復速度更快，併發症更少。

技術進步：

機器人技術的不斷進步正在提高手術機器人的功能和易用性。現代手術機器人正變得更加複雜、更容易使用且用途更加廣泛。這些進步正在擴大機器人手術在各種外科專業的應用範圍，包括心臟科、泌尿科、婦科和骨科。提高機器人靈活性、觸覺回饋和人工智慧整合等創新進一步突破了機器人手術所能實現的界限。

政府措施：

在一些國家，政府措施和支持性報銷政策正在促進手術機器人在醫療機構中的實施。這些努力通常包括資助機器人手術計畫、培訓醫療專業人員以及激勵醫院投資先進手術技術。支持政策將大大加速將機器人系統引入臨床實踐，使這些先進的手術更容易為患者所接受。

醫療保健效率：

手術機器人有潛力透過減少手術室時間和增強手術工作流程來提高醫療保健效率。 RAS 提供的精確度和控制可以實現更快、更有效率的手術，同時減少併發症。這些效率轉化為更低的整體醫療成本，因為更短的手術時間和更快的恢復減少了住院時間和相關成本。此外，外科手術量的增加使醫療機構能夠更有效地管理患者數量並改善獲得手術護理的機會。

主要問題

成本高：

手術機器人系統的高成本是其廣泛使用的主要障礙。這些先進的機器每台價值數百萬美元，這對醫院和外科中心來說是一項很高的初始投資。在預算有限的環境中，尤其是小型或農村醫療機構，可能很難分配購買和維護這些系統所需的資金。此外，除了初始購買成本外，維護、維修和更新成本也增加了財務資源的壓力。

限量兌換：

機器人手術的報銷政策可能不一致，並且因國家和醫療保健系統而異。在許多情況下，保險或政府報銷不能完全涵蓋與機器人手術相關的額外費用。這些經濟差異可能會使機器人手術對醫院來說不再有吸引力。如果報銷不能證明所產生的高成本是合理的，醫院可能不願意採用這些技術。

陡峭的學習曲線：

手術機器人的有效使用需要對外科醫生和手術人員進行廣泛的培訓。這種訓練既耗時又昂貴，因為它不僅涉及學習如何操作機器人系統，還涉及適應新的手術技術和方案。陡峭的學習曲線可能會延遲機器人手術計劃的採用，因為醫院在提供這些先進的手術之前必須在教育和培訓方面投入大量資源。增加負擔的是需要持續培訓以跟上技術進步。

缺乏長期數據：

儘管機器人手術的短期益處已有充分記錄，但仍缺乏將患者結果與傳統手術方法進行比較的全面長期數據。這種數據差距可能會導致外科醫生和患者猶豫不決，因為機器人輔助手術的長期療效和安全性尚不清楚。縱向研究對於更清楚瞭解 RAS 的好處和潛在風險至關重要，這將有助於就 RAS 實施做出明智的決策。

使用有限：

手術機器人並不適用於所有手術。這項技術仍處於起步階段，可能不適合傳統技術更有效或更具成本效益的手術。對於某些手術，機器人方法可能無法提供比傳統方法顯著的優勢，外科醫生可能更喜歡傳統技術。此外，用於特定外科手術的機器人系統的開發目前正在進行中，並且一些應用尚未針對臨床使用進行完全優化或驗證。

主要趨勢

人工智慧與機器學習的興起：

人工智慧 (AI) 和機器學習 (ML) 演算法的整合正在徹底改變機器人輔助手術。人工智慧可以協助外科醫生在手術過程中做出決策，分析患者數據以預測潛在的併發症，並自動執行重複性任務。此外，機器學習可以根據每位患者的解剖結構和病史定製手術程序，從而提高準確性和治療結果。

用途擴充：

手術機器人目前的應用範圍超出了傳統的泌尿科和婦科領域。在一般外科、心臟外科、頭頸外科等領域不斷出現新的用途。隨著機器人技術的進步，適合機器人支援的手術範圍不斷擴大，預計將在多種醫療領域中採用。

注重成本效益：

雖然負擔能力仍然是一個關鍵問題，但人們越來越重視成本控制解決方案。在開發低成本機器人系統、引入創新融資模式以及簡化手術工作流程以優化手術室時間方面正在取得進展。這些措施旨在使機器人輔助手術對於醫療保健提供者來說更容易獲得且經濟上可行。

遠距呈現與遠距手術：

技術的進步為遠端手術鋪平了道路，使外科醫生能夠從遠端位置操作機器人。這種能力有可能改善服務不足地區和緊急情況下獲得專業外科護理的機會。遠距呈現手術可能會徹底改變外科護理的提供方式，使更多的人能夠接受專門的手術。

增強的觸覺回饋：

目前的機器人系統已經改善了觸覺回饋，使外科醫生能夠在手術過程中感受到組織壓力和阻力。增強的觸覺回饋提供了更自然、直觀的體驗，更接近傳統開放性手術的感覺。這項進步使外科醫生能夠進行更精確、更自信的手術。

協作機器人的出現：

新一代協作手術機器人正在出現。這些機器人被設計為充當外科醫生的助手，而不是替代者，執行諸如握住手術器械和縮回組織等任務。這種協作方法可以提高手術效率、減少外科醫生疲勞並改善整體手術結果。

日益關注網路安全：

隨著手術機器人越來越多地與複雜的軟體和數據系統集成，網路安全問題變得至關重要。該行業致力於開發強大的網路安全措施，以保護患者資料並確保機器人系統的安全運作。擁有強大的網路安全協議對於保持機器人輔助手術的可靠和安全至關重要。

目錄

第1章全球手術機器人市場：簡介

• 市場概覽
• 調查範圍
• 先決條件

第 2 章執行摘要

第3章驗證市場研究研究方法

• 資料探勘
• 驗證
• 資料來源列表

第4章全球手術機器人市場展望

• 摘要
• 市場動態
  • 促進因素
  • 阻礙因素
  • 機會

第5章全球手術機器人市場：依組成部分

• 摘要
• 元件
  • 機器人系統
  • 設備及配件

第6章全球手術機器人市場：依應用劃分

• 摘要
  • 骨科
  • 神經外科
  • 一般外科
  • 婦科手術
  • 泌尿科
  • 其他

第7章全球手術機器人市場：依地區劃分

• 摘要
• 北美
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 其他拉丁美洲地區
• 中東/非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非
  • 其他中東和非洲地區

第8章全球手術機器人市場：競爭格局

• 摘要
• 企業市場排名
  • Intuitive Surgical, Inc. (US)
  • Stryker Corporation (US)
  • Mazor Robotics (Israel)
  • Hansen Medical (US)
  • TransEnterix, Inc. (US)
  • Medtech SA (France)
  • Merck Co. & Inc (US)
  • Verb Surgical Inc. (US)
  • Smith & Nephew (UK)
  • Renishaw PLC (UK)
  • Medrobotics Corporation (US)
• 主要發展策略

第 9 章附錄

• 相關報告

Surgical Robotics Market Size And Forecast

Surgical Robotics Market size was valued at USD 10.03 Billion in 2024 and is projected to reach USD 33.55 Billion by 2031, growing at a CAGR of 17.97% from 2024 to 2031. Surgical robotics is a type of minimally invasive surgery that utilizes computer-controlled robotic systems to assist surgeons during procedures. Robotic surgeries are procedures carried out employing automated technology. Robotically-assisted surgery was created to solve shortcomings in existing minimally invasive surgical procedures and to improve the ability of doctors doing traditional open surgeries. Instead of physically handling tools in robotically-assisted minimally invasive surgery, physicians use one of two approaches to control them. These methods include using a direct telemanipulator and computer control. A telemanipulator is a remote manipulator that allows surgeons to perform the precise movements required during surgery. Robotic arms then imitate these movements with end-effectors and equipment to carry out the surgical procedure. In computer-controlled systems, surgeons use computer orders to drive robotic arms and end-effectors, while these systems may still have telemanipulators for input.

One advantage of computerized control is that doctors are not required to be physically present, which could enable remote surgery. Memory devices are critical for guaranteeing seamless robot-assisted operations.

These storage solutions serve a variety of purposes depending on patients' medical records, including storing specific information for calibration adjustments, detecting differences in the storage determination system, and monitoring data longevity, among other things.

To Learn More:

Global Surgical Robotics Market Dynamics

The key market dynamics that are shaping the global surgical robotics market include:

Key Market Drivers

Minimally Invasive Approach:

Robotic-assisted surgery (RAS) offers a minimally invasive alternative to traditional open surgery. This approach results in several patient benefits, including smaller incisions, reduced blood loss, quicker recovery times, and less postoperative pain. The smaller incisions also lower the risk of infection and lead to minimal scarring, improving the overall patient experience and outcomes.

Enhanced Precision and Control:

RAS is the enhanced precision and control over surgical instruments. Robotic arms can execute movements with greater accuracy than human hands, minimizing hand tremors and enhancing surgical precision. This increased control is especially beneficial for complex and delicate procedures, where even minor errors can have significant consequences. Surgeons can perform intricate operations with improved accuracy, leading to better clinical outcomes.

Improved Visualization:

RAS systems are equipped with high-definition 3D cameras that provide magnified views of the surgical site. This advanced visualization allows surgeons to see anatomical structures in exceptional detail, facilitating more informed decision-making during surgery. The enhanced visibility of tissues and organs helps in identifying and preserving vital structures, reducing the likelihood of complications.

Growing Demand for Minimally Invasive Procedures:

The demand for minimally invasive procedures is rising as patients increasingly prefer these options over traditional open surgeries. The benefits of minimally invasive techniques, such as shorter recovery times, reduced pain, and quicker return to daily activities, are driving this trend. Consequently, there is a growing demand for surgical robots, which enable these less invasive procedures to be performed with greater precision and efficacy.

Aging Population:

The global population is aging, resulting in a higher demand for complex surgical procedures. Elderly patients often have comorbidities that make traditional open surgery riskier. RAS offers a safer alternative for these patients, as it reduces the physical trauma associated with surgery. The precision and minimally invasive nature of robotic surgery make it particularly suitable for elderly patients, who may experience faster recovery and fewer complications.

Technological Advancements:

Continuous advancements in robotics technology are enhancing the capabilities and usability of surgical robots. Modern surgical robots are becoming more sophisticated, user-friendly, and versatile. These advancements are expanding the range of applications for robotic surgery across various surgical specialties, including cardiology, urology, gynecology, and orthopedics. Innovations such as improved robotic dexterity, haptic feedback, and AI integration are further pushing the boundaries of what can be achieved with robotic surgery.

Government Initiatives:

In several countries, government initiatives and supportive reimbursement policies are promoting the adoption of surgical robots in healthcare facilities. These initiatives often include funding for robotic surgery programs, training for healthcare professionals, and incentives for hospitals to invest in advanced surgical technologies. Supportive policies can significantly accelerate the integration of robotic systems into clinical practice, making these advanced procedures more accessible to patients.

Increased Focus on Healthcare Efficiency:

Surgical robots have the potential to improve healthcare efficiency by reducing the time spent in the operating room and enhancing surgical workflows. The precision and control offered by RAS can lead to faster, more efficient surgeries with fewer complications. This efficiency can translate to lower overall healthcare costs, as shorter surgeries and quicker recoveries reduce hospital stays and associated expenses. Additionally, the increased throughput in surgical departments can help healthcare facilities manage patient loads more effectively, improving access to surgical care.

Key Challenges

High Cost:

The high cost of surgical robotic systems represents a significant barrier to widespread adoption. These advanced machines can cost millions of dollars each, making the initial investment steep for hospitals and surgical centers. Budget-constrained environments, particularly in smaller or rural healthcare facilities, may find it challenging to allocate the necessary funds for purchasing and maintaining these systems. Additionally, the cost extends beyond the initial purchase, encompassing maintenance, repairs, and updates, further straining financial resources.

Limited Reimbursement:

Reimbursement policies for robotic surgery procedures can be inconsistent, varying widely across countries and even within different healthcare systems. In many cases, insurance and government reimbursements may not fully cover the additional costs associated with robotic surgery. This financial gap can make robotic surgery a less attractive option for hospitals, as they might not recoup their investments adequately. Hospitals may hesitate to adopt these technologies if the reimbursement rates do not justify the higher expenses incurred.

Steep Learning Curve:

Effectively utilizing surgical robots requires extensive training for surgeons and surgical staff. This training is both time-consuming and costly, as it involves not only learning how to operate the robotic systems but also adapting to new surgical techniques and protocols. The steep learning curve can delay the implementation of robotic surgery programs, as hospitals need to invest significant resources in education and training before, they can offer these advanced procedures. The need for ongoing training to keep up with technological advancements adds to the burden.

Lack of Long-Term Data:

While the short-term benefits of robotic surgery are well-documented, there is still a lack of comprehensive long-term data comparing patient outcomes to those of traditional surgical methods. This gap in data can create hesitation among surgeons and patients, as they might be uncertain about the long-term efficacy and safety of robotic-assisted procedures. Long-term studies are crucial to provide a clearer understanding of the benefits and potential risks associated with RAS, which can help in making informed decisions about its adoption.

Limited Applications:

Surgical robots are not universally applicable to all types of surgery. The technology is still evolving and may not be suitable for certain procedures where traditional techniques are more efficient or cost-effective. For some operations, the robotic approach may not offer significant advantages over conventional methods, leading surgeons to prefer traditional techniques. Additionally, the development of robotic systems for specific surgical procedures is ongoing, and some applications are not yet fully optimized or validated for clinical use.

Key Trends

Rise of AI and Machine Learning:

The integration of artificial intelligence (AI) and machine learning (ML) algorithms is revolutionizing robotic-assisted surgery. AI can aid surgeons in decision-making during procedures, analyze patient data to predict potential complications and automate repetitive tasks. Additionally, ML can personalize surgical procedures by tailoring them to the individual patient's anatomy and medical history, enhancing precision and outcomes.

Expanding Applications:

Surgical robots are now being utilized beyond their traditional domains of urology and gynecology. New applications are emerging in general surgery, cardiac surgery, and head and neck surgery. As robotic technology continues to advance, the range of procedures suitable for robotic assistance is expanding, promising broader adoption across various medical specialties.

Focus on Cost-Effectiveness:

Affordability remains a significant challenge, but there is a growing emphasis on cost-containment solutions. Efforts are being made to develop more affordable robotic systems, introduce innovative financing models, and streamline surgical workflows to optimize operating room time. These measures aim to make robotic-assisted surgery more accessible and economically viable for healthcare providers.

Telepresence and Remote Surgery:

Technological advancements are paving the way for telepresence surgery, enabling surgeons to operate robots remotely from distant locations. This capability has the potential to improve access to specialized surgical care in underserved areas and during emergencies. Telepresence surgery could revolutionize how surgical care is delivered, making expert procedures available to a broader population.

Enhanced Haptic Feedback:

Current robotic systems are improving haptic feedback, allowing surgeons to feel the pressure and resistance of tissues during surgery. Enhanced haptic feedback provides a more natural and intuitive experience, closely mimicking the sensations of traditional open surgery. This advancement helps surgeons perform procedures with greater accuracy and confidence.

Emergence of Collaborative Robots:

A new generation of collaborative surgical robots is emerging. These robots are designed to act as assistants rather than replacements for surgeons, performing tasks such as holding surgical instruments or retracting tissues. This collaborative approach can enhance surgical efficiency, reduce surgeon fatigue, and improve overall procedural outcomes.

Growing Focus on Cybersecurity:

As surgical robots become increasingly integrated with complex software and data systems, cybersecurity concerns are becoming paramount. The industry is focusing on developing robust cybersecurity measures to protect patient data and ensure the safe operation of robotic systems. Implementing strong cybersecurity protocols is essential to maintaining trust and safety in robotic-assisted surgery.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Surgical Robotics Market Regional Analysis

Here is a more detailed regional analysis of the global surgical robotics market:

North America

North America is substantially dominating the global surgical robotics market owing to the increasing number of surgical procedures in North America is a major driver of market expansion.

As the population ages and chronic disorders requiring surgical intervention become more common, the demand for sophisticated surgical solutions grows. Robotic-assisted operations, which are noted for their precision and low invasive nature, are increasingly popular among both surgeons and patients.

North America is a hotbed of technological innovation, and surgical robotics is no exception. Continuous improvements in robotic technologies, including as improved robotic arms, advanced imaging systems, and sophisticated AI-driven capabilities, improve the efficacy and safety of surgical procedures.

These technical advancements make robotic-assisted procedures more accessible and effective, accelerating their acceptance across a variety of medical disciplines.

The North American region has a considerable influence on the worldwide surgical robot industry. The market is being driven by a high degree of knowledge about the benefits of robotic-assisted operations among healthcare professionals and patients alike.

Educational campaigns and professional training programs are improving surgeons' competency in using these advanced technologies, consequently expanding their acceptance and use.

Higher surgical robot adoption rates in North America are also driving market expansion. Robotic systems are progressively being integrated into operating rooms by hospitals and surgical centers because of their advantages in terms of precision, decreased recovery periods, and improved patient outcomes.

Healthcare providers' willingness to invest in these technologies, despite their high initial costs, demonstrates the perceived value and long-term advantages of robotically assisted surgery.

Asia Pacific

Asia Pacific is anticipated to be the fastest-growing region in the global surgical robotics market owing to the region's tremendous economic growth, which has a substantial impact on the healthcare sector.

This economic boom is driving up investments in healthcare infrastructure and the deployment of modern medical technologies such as surgical robots. The region's economic vigor provides a perfect setting for the implementation of cutting-edge surgical treatments.

Increasing geriatric population in the APAC area. Mirroring global trends, the demographic shift toward an older population is increasing the incidence of chronic diseases and, as a result, the demand for complex surgical treatments.

Surgical robots, noted for their minimally invasive nature, are becoming increasingly popular among patients and healthcare practitioners due to their ability to shorten recovery periods and enhance surgical results.

They also play an important role in the adoption of surgical robots in the Asia-Pacific area. Several governments are actively promoting the development and implementation of these technologies through generous reimbursement policies and financing programs. Such initiatives boost market expansion by making modern surgical procedures more accessible to healthcare facilities.

The APAC region bears a tremendous burden of chronic diseases, such as cancer and cardiovascular disease. These disorders necessitate complicated surgical treatments, and surgical robots provide minimally invasive alternatives that can improve patient outcomes while lowering total healthcare expenditures. The rising illness burden is pushing the demand for better surgical technology.

Additionally, there is a rising emphasis on minimally invasive surgery in the APAC area. Patients and healthcare providers are increasingly preferring these procedures to their associated benefits, such as speedier recovery and less pain.

Surgical robots are well-suited to address this demand, as they offer precise and efficient solutions for a wide range of surgical needs. This propensity for fewer intrusive treatments is helping surgical robots gain traction in the market.

Global Surgical Robotics Market: Segmentation Analysis

The Global Surgical Robotics Market is segmented based on Component, Application, And Geography.

Surgical Robotics Market, By Components

• Robot Systems
• Instruments and Accessories

Based on the Component, the Surgical Robotics Market is bifurcated into Robots System and Instruments and Accessories. The robotic systems segment is showing significant growth in the Global Surgical Robotics Market owing to the advanced features including 3D-HD imaging and a wide range of surgical equipment required for surgical procedures. These technologies not only help surgeons spot problems, but they also make it easier to perform difficult surgical procedures thanks to their improved visibility and magnification capabilities, fueling market growth. Furthermore, the operation of robotic systems significantly reduces the risk of errors and post-operative complications, assuring the continuous growth and implementation of robotic technology in surgical settings.

Surgical Robotics Market, By Application

• Orthopedic Surgery
• Neurosurgery
• General Surgery
• Gynaecology Surgery
• Urological Surgery

Based on the Application, the Surgical Robotics Market is bifurcated into Orthopedic Surgery, Neurosurgery, General Surgery, Gynaecology Surgery, and Urological Surgery. The gynecology market is expanding rapidly due to the increased use of robotically assisted surgery for a variety of gynecological procedures. These include benign hysterectomy, myomectomy, and gynecologic cancer operations, among others. The FDA's acceptance of the da Vinci surgical system for gynecologic surgery has greatly increased the number of robotic surgeries performed in this discipline. Furthermore, the increasing frequency of C-section procedures and the growing patient desire for minimally invasive robotic-assisted surgeries are likely to fuel industry growth.

Surgical Robotics Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Geography, the Global Surgical Robotics Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America is substantially dominating the Global Surgical Robotics Market owing to the increasing number of surgical procedures in North America is a major driver of market expansion. As the population ages and chronic disorders requiring surgical intervention become more common, the demand for sophisticated surgical solutions grows. Robotic-assisted operations, which are noted for their precision and low invasive nature, are increasingly popular among both surgeons and patients. North America is a hotbed of technological innovation, and surgical robotics is no exception. Continuous improvements in robotic technologies, including as improved robotic arms, advanced imaging systems, and sophisticated AI-driven capabilities, improve the efficacy and safety of surgical procedures.

Key Players

• The "Global Surgical Robots Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Intuitive Surgical, Inc., Stryker Corporation, Mazor Robotics, Hansen Medical, TransEnterix, Inc., Medtech SA, Merck Co. & Inc., Verb Surgical, Inc., Smith & Nephew, Renishaw PLC, Medrobotics Corporation.
• The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Surgical Robots Market Recent Developments
• In August 2021, Medtronic, a global leader in medical technology, is expected to reach some regulatory hurdles for its soft-tissue robot. CEO Geoff Martha revealed in a recent earnings call that the company is on its approach to submitting for a CE mark and is expecting a new device rejection from the FDA for the highly anticipated soft-tissue surgical robot.
• In February 2022, Kinova announced the signing of a five-year contract agreement with Auris Health. According to the agreement, the firm will work with Auris to develop its Monarch robotic-assisted surgery system.
• In November 2021, Merck & Co., Inc. announced that it is collaborating with Synthekine Inc. to use the latter's unique surrogate cytokine agonist participate in the discovery, development, and marketing of new cytokine therapies. Under the terms of the agreement, Synthekine will conduct initial research, while Merck will have exclusive rights to develop, manufacture, and commercialize surrogate cytokine agonists for up to two cytokines.

TABLE OF CONTENTS

1 INTRODUCTION OF THE GLOBAL SURGICAL ROBOTS MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 List of Data Sources

4 GLOBAL SURGICAL ROBOTS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities

5 GLOBAL SURGICAL ROBOTS MARKET BY COMPONENTS

• 5.1 Overview
• 5.2 Components
  • 5.2.1 Robot systems
  • 5.2.2 Instruments and accessories

6 GLOBAL SURGICAL ROBOTS MARKET BY APPLICATION

• 6.1 OVERVIEW
  • 6.1.1 Orthopaedic surgery
  • 6.1.2 Neurosurgery
  • 6.1.3 General surgery
  • 6.1.4 Gynaecology surgery
  • 6.1.5 Urologic Surgery
  • 6.1.6 Others

7 GLOBAL SURGICAL ROBOTS MARKET BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Argentina
  • 7.5.3 Rest of Latin America
• 7.6 Middle East and Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 UAE
  • 7.6.3 South Africa
  • 7.6.4 Rest of Middle East and Africa

8 GLOBAL SURGICAL ROBOTS MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
  • 8.2.1 Intuitive Surgical, Inc. (US),
  • 8.2.2 Stryker Corporation (US),
  • 8.2.3 Mazor Robotics (Israel),
  • 8.2.4 Hansen Medical (US),
  • 8.2.5 TransEnterix, Inc. (US),
  • 8.2.6 Medtech SA (France),
  • 8.2.7 Merck Co. & Inc (US),
  • 8.2.8 Verb Surgical Inc. (US),
  • 8.2.9 Smith & Nephew (UK),
  • 8.2.10 Renishaw PLC (UK),
  • 8.2.11 Medrobotics Corporation (US)
• 8.3 Key Development Strategies

9 Appendix

• 9.1.1 Related Reports